Earnings Feed
Start Free
Home/Filings/4/0001127602-21-028481
4//SEC Filing

Roberts Jonathan C 4

Accession 0001127602-21-028481

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Nov 4, 8:00 PM ET

Accepted

Nov 5, 4:35 PM ET

Size

21.9 KB

Accession

0001127602-21-028481

Insider Transaction Report

Form 4
Period: 2021-11-03
CVS HEALTH CorpCVS
Roberts Jonathan C
SVP and CIO
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-03$45.93/sh+108,870$5,000,399→ 215,984.717 total
  • Sale

    Common Stock

    2021-11-03$95.00/sh−108,870$10,342,650→ 107,114.717 total
  • Exercise/Conversion

    Stock Option

    2021-11-03−108,870→ 0 total
    Exercise: $45.93From: 2015-09-04Exp: 2022-09-04→ Common Stock (108,870 underlying)
Holdings

  • Common Stock

    (indirect: By GRAT)
    34,707

  • Stock Unit

    337,833.337

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (1,422.671 underlying)
    1,422.671

  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (68,482 underlying)
    68,482

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (248,131 underlying)
    248,131

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (303,010 underlying)
    303,010

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (239,355 underlying)
    239,355

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (172,772 underlying)
    172,772

  • Common Stock (restricted)

    12,812

  • ESOP Common Stock

    (indirect: By ESOP)
    6,045

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (161,318 underlying)
    161,318

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (200,358 underlying)
    200,358
Footnotes (11)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F10]Options became exercisable in four equal installments, commencing 4/1/2021.
  • [F11]Option becomes exercisable in four equal installments, commencing 4/1/2022.
  • [F2]Option became exercisable in three equal annual installments, commencing 9/4/2015.
  • [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F9]The number of shares subject to the option were calculated using a 30-day average price.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001410515

Filing Metadata

Form type
4
Filed
Nov 4, 8:00 PM ET
Accepted
Nov 5, 4:35 PM ET
Size
21.9 KB
View on SEC.gov